![Richard Lim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Lim
Amministratore Delegato presso
Xenimmune Therapeutics, Inc.
Profilo
Richard J.
Lim is the founder of Cure Ventures Management LP, founded in 2021, where the title held is Managing Partner.
Current jobs include Chief Executive Officer & Director at Xenimmune Therapeutics, Inc., and Catalyst Advisory at Massachusetts Institute of Technology.
Former jobs include Director at Spherics, Inc., HydroCision, Inc., Trident Pharmaceuticals, Inc., Gossamer Bio, Inc., and Nuvation Bio Operating Co., Inc.; Managing Director at Omega Fund Management LLC from 2008 to 2020; Independent Director at Paratek Pharmaceuticals, Inc. from 2014 to 2018; Vice President at Saunders Karp & Megrue Partners LLC; Manager at The Lek; General Partner at MVM Partners LLP from 2002 to 2008; Associate at Wolfensohn & Co., Inc.; and Member-Executive Board at Danish BioVenture General Partner ApS.
Education includes undergraduate degree from Harvard University in 1993 and MBA from Harvard Business School in 1998.
Posizioni attive di Richard Lim
| Società | Posizione | Inizio |
|---|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Fondatore | 01/07/2021 |
Xenimmune Therapeutics, Inc.
 Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection | Amministratore Delegato | - |
Precedenti posizioni note di Richard Lim
| Società | Posizione | Fine |
|---|---|---|
Danish BioVenture General Partner ApS
 Danish BioVenture General Partner ApS Financial ConglomeratesFinance Operates as a general partner and renders investment advice to K/S Danish BioVenture | Direttore/Membro del Consiglio | - |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Investitore di Private Equity | 01/01/2020 |
| GOSSAMER BIO, INC. | Direttore/Membro del Consiglio | 19/12/2018 |
| PARATEK PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 11/04/2018 |
Spherics, Inc.
 Spherics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore/Membro del Consiglio | 07/01/2010 |
Formazione di Richard Lim
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Spherics, Inc.
Spherics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
HydroCision, Inc.
 HydroCision, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets fluid-jet based surgical tools | Health Technology |
Trident Pharmaceuticals, Inc.
 Trident Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel biologics for the treatment of autoimmune disorders | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saunders Karp & Megrue Partners LLC
 Saunders Karp & Megrue Partners LLC Financial ConglomeratesFinance Private equity firm | Finance |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
Wolfensohn & Co., Inc.
 Wolfensohn & Co., Inc. Investment Banks/BrokersFinance Provides investment banking and financial advisory services | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
Danish BioVenture General Partner ApS
Danish BioVenture General Partner ApS Financial ConglomeratesFinance Operates as a general partner and renders investment advice to K/S Danish BioVenture | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
Xenimmune Therapeutics, Inc.
Xenimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody-enzyme fusion to target tumors and trigger the hyper-acute rejection | Health Technology |
